Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3708994018 | Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3708995017 | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Has active ingredient | Entacapone | true | Inferred relationship | Some | 1 | |
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Is a | Carbidopa- and entacapone- and levodopa-containing product | true | Inferred relationship | Some | ||
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Has active ingredient | Carbidopa | true | Inferred relationship | Some | 3 | |
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Is a | Carbidopa- and levodopa-containing product in oral dose form | true | Inferred relationship | Some | ||
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Has active ingredient | Levodopa | true | Inferred relationship | Some | 2 | |
Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Is a | Entacapone-containing product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Carbidopa and entacapone and levodopa only product in oral dose form | Is a | True | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 37.5 mg and entacapone 200 mg and levodopa 150 mg oral tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some | |
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Is a | False | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets